AppAsia Berhad (KLSE:APPASIA)

Achilles Therapeutics Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.15	12.77	7.99	4.72	9.16	14.41
Short-Term Investments	-	0.19	0.2	0.2	2.15	0.12
Cash & Short-Term Investments	11.15	12.96	8.19	4.92	11.32	14.53
Cash Growth	296.02%	58.18%	66.59%	-56.56%	-22.09%	33.48%
Accounts Receivable	25.4	22.37	14.85	15.87	9.59	11.09
Other Receivables	2.26	1.2	0.75	1.64	3.69	1.99
Receivables	27.66	23.57	15.6	17.51	13.28	13.09
Inventory	-	-	-	-	-	0.06
Prepaid Expenses	-	0.23	0.21	0.2	0.19	0.38
Total Current Assets	38.81	36.75	24	22.62	24.79	28.06
Property, Plant & Equipment	1.44	1.02	0.92	0.94	0.61	0.69
Other Intangible Assets	-	-	-	-	-	0.09
Long-Term Accounts Receivable	0.08	0.08	0.05	0.46	0.35	0.78
Long-Term Deferred Charges	0.12	0.21	0.68	1.29	2.09	2.74
Other Long-Term Assets	4.46	4.2	2.7	2.67	2.2	2.25
Total Assets	44.91	42.26	28.35	27.97	30.04	34.61
Accounts Payable	0.12	0.12	0.6	0.32	0.05	0.63
Accrued Expenses	-	0.86	0.81	0.53	0.5	0.6
Current Portion of Leases	0.38	0.09	0.4	0.41	0.04	0.05
Current Income Taxes Payable	0	0	0.01	0	0.04	0.01
Current Unearned Revenue	-	0.01	0.53	0.25	0.6	0.34
Other Current Liabilities	2.64	1.47	1.06	2.35	4.86	4.07
Total Current Liabilities	3.14	2.55	3.41	3.87	6.1	5.69
Long-Term Leases	0.25	0.09	0.07	0.01	0.03	0.07
Total Liabilities	3.39	2.63	3.47	3.88	6.13	5.76
Common Stock	45.66	43.54	32.1	30.73	30.73	28.93
Retained Earnings	6.17	5.07	2.51	0.57	-0.04	0.28
Treasury Stock	-10.37	-10.37	-10.37	-7.57	-7.17	-0.99
Comprehensive Income & Other	0.07	1.39	0.92	0.6	0.6	0.71
Total Common Equity	41.53	39.63	25.17	24.33	24.11	28.92
Minority Interest	-	-	-0.29	-0.24	-0.2	-0.07
Shareholders' Equity	41.53	39.63	24.88	24.1	23.91	28.85
Total Liabilities & Equity	44.91	42.26	28.35	27.97	30.04	34.61
Total Debt	0.63	0.17	0.47	0.42	0.07	0.12
Net Cash (Debt)	10.52	12.78	7.72	4.5	11.25	14.41
Net Cash Growth	330.05%	65.52%	71.65%	-60.01%	-21.92%	32.97%
Net Cash Per Share	0.01	0.01	0.01	0.00	0.01	0.01
Filing Date Shares Outstanding	1,378	1,395	1,095	1,079	1,082	1,062
Total Common Shares Outstanding	1,378	1,370	1,087	1,077	1,082	1,073
Working Capital	35.67	34.2	20.59	18.75	18.7	22.37
Book Value Per Share	0.03	0.03	0.02	0.02	0.02	0.03
Tangible Book Value	41.53	39.63	25.17	24.33	24.11	28.84
Tangible Book Value Per Share	0.03	0.03	0.02	0.02	0.02	0.03
Machinery	-	1.95	1.47	1.53	1.33	1.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.